Bora Pharmaceuticals Co., LTD.

TWSE:6472 주식 보고서

시가총액: NT$88.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Bora Pharmaceuticals 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Bobby Sheng

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기9.9yrs
CEO 소유권6.9%
경영진 평균 재임 기간6.9yrs
이사회 평균 재임 기간8.2yrs

최근 관리 업데이트

Recent updates

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

CEO

Bobby Sheng

9.9yrs

테뉴어

Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...


리더십 팀

이름위치테뉴어보상소유권
Pao-Shi Sheng
Chairmanno data데이터 없음6.86%
NT$ 6.1b
Alice Wang
CFO of HQ & APAC11.5yrs데이터 없음데이터 없음
Ellen Chen
Corporate Human Resource Director2.5yrs데이터 없음데이터 없음
Shih-Min Chen
VP & Director11.3yrs데이터 없음1.11%
NT$ 979.2m
Sally Langa
Senior VP of Marketing and Sales - CDMO Businessno data데이터 없음데이터 없음
Marcel Vieno
CFO of North Americano data데이터 없음데이터 없음
Tom Chang
Senior Vice President of Taiwan Site Operations1.5yrs데이터 없음데이터 없음
Xiu-Rong Zhang
Deputy General Managerno data데이터 없음0.010%
NT$ 9.0m
Zhen-Tang Zhang
Deputy General Managerno data데이터 없음0.097%
NT$ 86.0m

6.9yrs

평균 재임 기간

경험이 풍부한 관리: 6472 의 관리팀은 노련하고 경험 (평균 재직 기간 6.8 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Pao-Shi Sheng
Chairman9.9yrs데이터 없음6.86%
NT$ 6.1b
Shih-Min Chen
VP & Director9.9yrs데이터 없음1.11%
NT$ 979.2m
Jui-Yi Lin
Independent Director9.3yrs데이터 없음데이터 없음
Shang-Hung Shen
Director9.9yrs데이터 없음데이터 없음
Kuan-Pai Chen
Director5.1yrs데이터 없음데이터 없음
Ming-Jung Lai
Independent Director7.1yrs데이터 없음데이터 없음
Yi-Chin Lee
Independent Director7.1yrs데이터 없음0.032%
NT$ 28.5m
Hsin-I Lin
Independent Director1.1yrs데이터 없음0.00099%
NT$ 876.5k

8.2yrs

평균 재임 기간

경험이 풍부한 이사회: 6472 의 이사회경험(평균 재직 기간 8.1 년)으로 간주됩니다.